BioSpace News Archive

Drug Development

Oyster Point Announces Positive Results From Two Separate Phase 2b Clinical Trials of the Company’s Investigational Treatments for Dry Eye Disease

Two Lead Clinical Candidates are Delivered as a Nasal Spray to Stimulate the Trigeminal Parasympathetic Pathway to Promote Natural Tear Film Production

October 24, 2018
·
5 min read
BioCapital

GlycoMimetics to Present at Upcoming November 2018 Investor Conferences

GlycoMimetics, Inc. today announced that Chief Executive Officer Rachel King will provide a company overview at two upcoming investor conferences, as follows

October 24, 2018
·
1 min read
Drug Development

vTv Therapeutics Presents Positive Data on the Effect of Azeliragon in Patients with Alzheimer’s and Diabetes at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Subgroup Analysis Indicates Potential Benefit of Treatment with Azeliragon for Patients with Type 2 Diabetes and Alzheimer’s Disease

October 24, 2018
·
6 min read
Business

The National Cybersecurity Center of Excellence Partners With Zingbox on Medical Device Security Project

Zingbox is a provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform and a leader in healthcare IoT research

October 24, 2018
·
2 min read
Vetter Further Expands Secondary Packaging

Pharmaceutical service provider relies on expanded capacities, modular production and modern analytics

October 24, 2018
·
4 min read
Marapharm Ventures Inc. Changes Name to Liht Cannabis Corp.

No action is required to be taken by current shareholders in connection with the change, and no change has been made to Liht Cannabis Corp. share capital.

October 24, 2018
·
7 min read
Deals

Riverchase Dermatology and Cosmetic Surgery Acquires Wittenborn Plastic Surgery and Welcomes William S. Wittenborn, M.D.

Riverchase Dermatology and Cosmetic Surgery is proud to announce the acquisition of Wittenborn Plastic Surgery, practice of William S. Wittenborn, M.D.

October 24, 2018
·
2 min read
BioCapital

CareFirst Awards Nearly $2.1M to Substance Use Disorder Treatment, Prevention Programs

Grants to nonprofits intended to help curb opioid use, other addiction problems

October 24, 2018
·
4 min read
Business

Eisai and Oklahoma Health Care Authority Enter Value-Based Agreement for FYCOMPA

Eisai Inc. announced today that they have signed a value-based contract for FYCOMPA® (perampanel) CIII with Oklahoma Health Care Authority (OHCA) premised on reduction of hospitalizations of OHCA patients with epilepsy.

October 24, 2018
·
10 min read
Business

Mentice Appoints New Member to its Board of Directors.

Mentice announced today the appointment of a new independent member to its Board of Directors.

October 24, 2018
·
2 min read